therapeutic areas banner

Our therapies mobile banner

OXLUMO® (lumasiran) - Alnylam Therapies

Select below to explore a breadth of educational, scientific, and clinical resources related to the FDA-approved uses of our therapies.

illuminate-clinical-trial-program-overview

This infographic details the ILLUMINATE clinical trial program which investigates the treatment of Primary Hyperoxaluria Type 1 with lumasiran.

View Material

Explore Additional Resources & Support

Ph1-oxlumo

Primary Hyperoxaluria Type 1 (PH1)

Learn more about Primary Hyperoxaluria Type 1 (PH1)

Connect with Alnylam Medical

Reach our medical team for scientific information, resources, and support

Login-Signup Banner

Left Image

RNAiScience is for US healthcare professionals. By creating an account, you will have access to:

- All RNAi on-demand educational content
- Personalization experience with ability to bookmark content for future reference

First Name *

Last Name *

Enter your Institution Email *

Password *

Country *

Select Specialty *

Select Profession *

* Required Fields

By signing up you agree to Alnylam Terms of Conditions and Privacy Policy.

Search for educational content on Disease & Therapeutic Areas and Alnylam Therapies

Use the "Search" feature to discover Disease & Therapeutic Area educational content based on key terms
More than one search term is recommended to yield the most relevant results
By searching, you confirm that your query is unsolicited

Search Congress and Publication resources

Use the "Search" feature to discover Congresses & Publications resources based on key terms
More than one search term is recommended to yield the most relevant results
By searching, you confirm that your query is unsolicited